PULMOGENIX

PulmoGeniX™ is developing a comprehensive device-based treatment intended to diagnose and treat asthma. The technology was invented to reduce bronchial smooth muscle to eliminate its ability to constrict and, thus, dramatically decrease asthma attacks. It is designed to treat a greater number of airways simultaneously, to be less technically challenging for the physician, to be performed within one procedural visit, and to be less expensive for the patient... PulmoGeniX is focused initially on delivering a cost-effective, device-based treatment that combines physiologic metrics and real-time biofeedback with therapeutic intervention to diagnose and treat bronchial smooth muscle within one procedural visit to dramatically decrease asthma attacks in severe asthma patients... PulmoGeniX™ Technologies, Inc. is an emerging medical device company focused on commercializing significant innovations developed by Mayo Clinic to treat and cure asthma. Its initial focus in the joint development..

Also known as: PulmoGeniX Technologies, PulmoGeniX Technologies, Inc., PulmoGeniX, Inc.